STAT1d
Pharmalittle: We’re reading about Trump rescinding drug-pricing tests, a Walgreens opioid suit, and more
President Trump rescinded an executive order that prompted the creation of three Medicare drug-pricing experiments ...
pharmaphorum24d
AstraZeneca, Honeywell partner to address climate change with new inhaler tech
UK-based global pharma company AstraZeneca and US consumer products company Honeywell have announced a partnership to build a new "next generation" inhaler with a propellant that reduces Global ...
The Financial Express3d
AstraZeneca’s Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Pharmaceutical Technology5d
COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio growth
The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.